G1 Therapeutics Stock Price on June 24, 2022
| GTHX Stock | USD 4.10 0.01 0.24% |
Below is the normalized historical share price chart for G1 Therapeutics extending back to May 17, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of G1 Therapeutics stands at 4.10, as last reported on the 23rd of April, with the highest price reaching 4.20 and the lowest price hitting 3.95 during the day.
If you're considering investing in GTHX Stock, it is important to understand the factors that can impact its price. G1 Therapeutics appears to be very risky, given 3 months investment horizon. G1 Therapeutics retains Efficiency (Sharpe Ratio) of 0.078, which attests that the company had a 0.078% return per unit of price deviation over the last 3 months. By inspecting G1 Therapeutics' technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please utilize G1 Therapeutics' Standard Deviation of 9.71, market risk adjusted performance of 0.1413, and Semi Deviation of 10.73 to validate if our risk estimates are consistent with your expectations.
At this time, G1 Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 856.1 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 33.7 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 0.06 in 2024, whereas Price To Sales Ratio is likely to drop 1.82 in 2024. GTHX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of May 2017 | 200 Day MA 2.578 | 50 Day MA 3.6761 | Beta 1.695 |
GTHX |
Sharpe Ratio = 0.078
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GTHX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.95 actual daily | 87 87% of assets are less volatile |
Expected Return
| 0.78 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average G1 Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of G1 Therapeutics by adding it to a well-diversified portfolio.
Price Book 6.7119 | Enterprise Value Ebitda (6.16) | Price Sales 2.8785 | Shares Float 43.6 M | Wall Street Target Price 8.5 |
G1 Therapeutics Valuation on June 24, 2022
It is possible to determine the worth of G1 Therapeutics on a given historical date. On June 24, 2022 GTHX was worth 5.36 at the beginning of the trading date compared to the closed value of 5.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of G1 Therapeutics stock. Still, in general, we apply an absolute valuation method to find G1 Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of G1 Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against G1 Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 4.96 | 5.31 | 4.96 | 5.30 | 1,045,700 | |
06/24/2022 | 5.36 | 5.61 | 5.25 | 5.54 | 5,265,000 |
| 5.47 | 5.62 | 5.16 | 5.35 | 751,900 |
| Backtest G1 Therapeutics | | | G1 Therapeutics History | | | G1 Therapeutics Valuation | Previous | Next |
G1 Therapeutics Trading Date Momentum on June 24, 2022
| On June 27 2022 G1 Therapeutics was traded for 5.35 at the closing time. The top price for the day was 5.62 and the lowest listed price was 5.16 . The trading volume for the day was 751.9 K. The trading history from June 27, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.43% . The overall trading delta against the current closing price is 7.76% . |
G1 Therapeutics Fundamentals Correlations and Trends
By evaluating G1 Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among G1 Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GTHX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About G1 Therapeutics Stock history
G1 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GTHX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in G1 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing G1 Therapeutics stock prices may prove useful in developing a viable investing in G1 Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.7 M | 33.7 M | |
| Net Loss | -132.8 M | -126.2 M |
G1 Therapeutics Quarterly Net Working Capital |
|
G1 Therapeutics Stock Technical Analysis
G1 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
G1 Therapeutics Period Price Range
Low | June 24, 2022
| High |
5.36 | 5.54 |
G1 Therapeutics April 23, 2024 Market Strength
Market strength indicators help investors to evaluate how G1 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading G1 Therapeutics shares will generate the highest return on investment. By undertsting and applying G1 Therapeutics stock market strength indicators, traders can identify G1 Therapeutics entry and exit signals to maximize returns
| Accumulation Distribution | 337861.0 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 5.43 | |||
| Day Typical Price | 5.47 | |||
| Price Action Indicator | 0.2 | |||
| Period Momentum Indicator | (1.44) |
G1 Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for G1 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of GTHX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GTHX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0622 | |||
| Jensen Alpha | 0.3529 | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | 0.0675 | |||
| Treynor Ratio | 0.1313 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in G1 Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more information on how to buy GTHX Stock please use our How to Invest in G1 Therapeutics guide.Note that the G1 Therapeutics information on this page should be used as a complementary analysis to other G1 Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for GTHX Stock analysis
When running G1 Therapeutics' price analysis, check to measure G1 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy G1 Therapeutics is operating at the current time. Most of G1 Therapeutics' value examination focuses on studying past and present price action to predict the probability of G1 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move G1 Therapeutics' price. Additionally, you may evaluate how the addition of G1 Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is G1 Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of G1 Therapeutics. If investors know GTHX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about G1 Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Revenue Per Share 1.595 | Quarterly Revenue Growth 0.451 | Return On Assets (0.16) | Return On Equity (0.92) |
The market value of G1 Therapeutics is measured differently than its book value, which is the value of GTHX that is recorded on the company's balance sheet. Investors also form their own opinion of G1 Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is G1 Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because G1 Therapeutics' market value can be influenced by many factors that don't directly affect G1 Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between G1 Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if G1 Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, G1 Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.